文献速递儿童康复神经康复

参与导向疗法对脑瘫儿童身体活动参与目标表现与习惯性身体活动的疗效:一项随机对照试验

Efficacy of Participation-Focused Therapy on Performance of Physical Activity Participation Goals and Habitual Physical Activity in Children With Cerebral Palsy: A Randomized Controlled Trial.
PubMed 文献 · Arch Phys Med Rehabil · 2018-12-11

该随机等待列表对照试验纳入37例GMFCS I-III级脑瘫儿童,评估8周参与导向疗法(ParticiPAte CP)的疗效。结果显示干预显著改善目标表现、满意度及参与障碍,但未显著改变平均中高强度身体活动时间;基线未达活动指南者可能对干预有临床意义的反应。

要点

  • ParticiPAte CP可显著改善脑瘫儿童身体活动参与目标的表现与满意度。
  • 干预未显著增加平均中高强度身体活动时间,但低活动儿童可能获益。
  • 参与障碍的减少是干预改善目标表现的可能机制。

核心结论

  • ParticiPAte CP通过减少可改变的参与障碍,有效提高GMFCS I-III级脑瘫儿童感知的身体活动参与目标表现。
  • 干预未在平均水平上转化为习惯性身体活动的改变,但低活动儿童可能具有临床意义的反应。

研究设计与样本

  • 随机等待列表对照试验,从人群登记处招募37例GMFCS I-III级脑瘫儿童(18例男性,平均年龄10.0±1.4岁)。
  • 参与者随机接受8周由物理治疗师实施的个体化参与导向疗法(ParticiPAte CP)或等待列表常规照护。
  • 主要结局为加拿大作业表现测量,并使用加速度计客观测量习惯性身体活动。

主要发现

  • 8周时,ParticiPAte CP组在目标表现(平均差=3.58;95%CI 2.19-4.97;P<.001)和满意度(平均差=1.87;95%CI 0.37-3.36;P=.014)上显著优于常规照护组。
  • 8周时,参与障碍组间差异显著(平均差=26.39;95%CI 6.13-46.67;P=.011)。
  • 8周时,每日中高强度身体活动分钟数无组间差异(平均差=1.17;95%CI -13.27至15.61;P=.874)。
  • 基线是否达到习惯性身体活动指南对干预反应有显著影响(平均差=15.85;95%CI 3.80-27.89;P<.0061)。
  • ParticiPAte CP后,低活动参与者的平均中高强度身体活动增加5.98±12.16分钟/天。

关键数值与推荐

  • 目标表现改善:平均差=3.58(95%CI 2.19-4.97;P<.001)。
  • 满意度改善:平均差=1.87(95%CI 0.37-3.36;P=.014)。
  • 参与障碍改善:平均差=26.39(95%CI 6.13-46.67;P=.011)。
  • 中高强度身体活动无组间差异:平均差=1.17(95%CI -13.27至15.61;P=.874)。
  • 基线活动指南达标与否的干预反应差异:平均差=15.85(95%CI 3.80-27.89;P<.0061)。

临床怎么用

  • 对GMFCS I-III级脑瘫儿童,可考虑采用8周个体化参与导向疗法以改善身体活动参与目标的表现与满意度。
  • 干预应着重识别并减少可改变的参与障碍。
  • 对基线低活动的脑瘫儿童,该干预可能带来有临床意义的中高强度身体活动增加。

局限性

  • 样本量较小(n=37),可能影响结果的精确性与推广性。
  • 干预周期为8周,缺乏长期疗效数据。
  • 习惯性身体活动在平均水平未显著改变,客观活动结局的改善有限。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To determine the efficacy of a participation-focused therapy (ParticiPAte CP) on leisure-time physical activity goal performance and satisfaction and habitual physical activity (HPA) in children with CP. DESIGN: Randomized waitlist-controlled trial. SETTING: Home and community. PARTICIPANTS: Children classified at Gross Motor Function Classification System (GMFCS) levels I-III were recruited (n=37; 18 males; mean age ± SD, 10.0±1.4y) from a population-based register. INTERVENTIONS: Participants were randomized to ParticiPAte CP (an 8-wk goal-directed, individualized, participation-focused therapy delivered by a physical therapist) or waitlist usual care. MAIN OUTCOME MEASURES: The primary outcome was Canadian Occupational Performance Measure. Accelerometers were worn for objective measurement of HPA (min/d moderate-to-vigorous physical activity [MVPA], sedentary time). Barriers to participation, community participation, and quality-of-life outcomes were also collected. Data were analyzed by intention-to-treat using generalized estimating equations. RESULTS: ParticiPAte CP led to significant improvements in goal performance (mean difference [MD]=3.58; 95% confidence interval [95% CI], 2.19-4.97; P<.001), satisfaction (MD=1.87; 95% CI, 0.37-3.36, P=.014), and barriers to participation (MD=26.39; 95% CI, 6.13-46.67; P=.011) compared with usual care at 8 weeks. There were no between-group differences on minutes per day of MVPA at 8 weeks (MD=1.17; 95% CI, -13.27 to 15.61; P=.874). There was a significant difference in response to intervention between participants who were versus were not meeting HPA guidelines at baseline (MD=15.85; 95% CI, 3.80-27.89; P<.0061). After ParticiPAte CP, low active participants had increased average MVPA by 5.98±12.16 minutes per day. CONCLUSION: ParticiPAte CP was effective at increasing perceived performance of leisure-time physical activity goals in children with CP GMFCS I-III by reducing modifiable barriers to participation. This did not translate into change in HPA on average; however, low active children may have a clinically meaningful response.

来源:Arch Phys Med Rehabil,查看原文。版权归原作者所有。

引用

  1. Reedman SE, Boyd RN, Trost SG, et al. Efficacy of Participation-Focused Therapy on Performance of Physical Activity Participation Goals and Habitual Physical Activity in Children With Cerebral Palsy: A Randomized Controlled Trial. Arch Phys Med Rehabil. 2018. PMID: 30543803. doi:10.1016/j.apmr.2018.11.012

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。